Lifeward (LFWD) Stock Analysis & Winston Score
Lifeward Ltd. is a medical device company that makes robotic systems to help people with mobility disabilities walk again. Its main product is the ReWalk exoskeleton, a wearable robotic suit that straps onto a person's legs and helps them stand up and walk. The company sells primarily to rehabilitation hospitals, veterans' programs, and individual patients, mostly in the United States and Europe. Lifeward earns money by selling its exoskeleton devices and through service and support contracts. The company is small, with a market cap near zero, and it operates at a significant loss — spending far more than it brings in each year. ReWalk was one of the first FDA-cleared powered exoskeletons for home use, which gives it a regulatory head start, but the company faces intense pressure to expand insurance coverage for its devices, since limited reimbursement from insurers remains the biggest barrier to wider adoption and a path to profitability.
Winston Score: 14/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (4/30)
- Growth: Weak (1/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (2/10)
- Valuation: Data not available (0/10)
- Ownership: Mixed (6/15)
Key Facts
Price: $7.91
Market Cap: $13M
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ Capital Market
